ロード中...
FGF21 and Cardiac Physiopathology
The heart is not traditionally considered either a target or a site of fibroblast growth factor-21 (FGF21) production. However, recent findings indicate that FGF21 can act as a cardiomyokine; that is, it is produced by cardiac cells at significant levels and acts in an autocrine manner on the heart...
保存先:
| 出版年: | Front Endocrinol (Lausanne) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4553397/ https://ncbi.nlm.nih.gov/pubmed/26379627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2015.00133 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|